Montelukast Generics (Montelukast)

Montelukast blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotriene D4 from triggering bronchoconstriction, mucus secretion, and inflammatory cell recruitment. This antagonism reduces airway narrowing and allergic inflammation, improving breathing and nasal symptoms.

The dosage of Montelukast Generics is determined by the prescribing healthcare professional based on the patient’s age, condition, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for Montelukast in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks before prescribing to pregnant or nursing women. Women should discuss any concerns with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and required import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids and long‑acting beta‑agonists. It is particularly useful for patients with aspirin‑sensitive asthma or those who prefer a non‑inhaled option, though it may be less potent for acute symptom relief.

Montelukast Generics should be stored at temperatures below 25 °C, in the original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool place helps maintain its stability and potency.

Montelukast Generics is taken orally, usually once daily in the evening, with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare provider.

Serious risks include rare allergic reactions such as angioedema or anaphylaxis, neuropsychiatric events like depression or suicidal thoughts, and severe liver enzyme elevations. Patients should seek immediate medical attention if they experience any of these symptoms.

Montelukast Generics should be avoided in individuals with known hypersensitivity to montelukast or any component of the formulation. Caution is also advised for patients with severe hepatic impairment, and it is not recommended for acute asthma attacks.